- Global Pharma News & Resources

Global Dyspepsia Drug Market Size,Share, Emerging Trends, Regional Analysis, Segments,Players-KOREA UNITED PHARM INC., Astellas Pharma Inc, Eisai Co., Ltd, ZERIA Pharmaceutical Co.,Ltd, DONG – A ST, Beactica AB

Data Bridge Market Research Adds “Global Dyspepsia Drug Market – Industry Trends and Forecast to 2026” new report to its research database. The report spread No of pages : 350 No of Figures: 60 No of Tables: 220 in it.

This comprehensive Dyspepsia Drug industry research report includes a brief on these trends that can help the organizations operating in the industry to understand the market and strategize for their business expansion accordingly. The research report analyzes the market CAGR,Volume, industry share And size, demand and trend growth, key segments, and key drivers and restrains. New Players in the market are facing tough competition from established international  Players as they struggle with technological innovations, reliability and quality issues. The report will answer questions about the current market developments and the scope of competition, opportunity cost and more.

Download Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @

Global dyspepsia drug market is expected to grow at a healthy CAGR in the forecast period of 2019-2026. Growing incidence of dyspepsia’s population and development of advanced therapies and treatment are the key factors for market growth.

Competitive Analysis:

Global dyspepsia drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global dyspepsia drug market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

Few of the major competitors currently working in the global dyspepsia drug market are AstraZeneca, Biogen, KOREA UNITED PHARM INC., Astellas Pharma Inc, Eisai Co., Ltd, ZERIA Pharmaceutical Co.,Ltd, DONG – A ST, Beactica AB, Xian Janssen Pharmaceutical Ltd, Novartis AG, YUHAN, Abide Therapeutics, Inc, Daewoong Co., Ltd, Takeda Pharmaceutical Company Limited, Ironwood Pharmaceuticals, Inc, RedHill, ADM Biopolis, LUPIN, Johnson & Johnson Services, Inc. and others.

Market Drivers

  • Growing cases of dyspepsia worldwide boosts the market growth
  • Rise in prevalence of metabolic disorders like diabetes mellitus and endocrine disorders such as hypothyroid, hyperparathyroid, Addison’s disease, uraemia and others are the conditions which interrupt the digestion which act as a market driver
  • High prevalence of digestive diseases such as digestive ulcers and gastric erosions also drives the market growth
  • Chronic consumption of alcohol, smoking and caffeine acts as a driver for the market growth

Market Restraints

  • Patent expiry from many companies and introduction of generic drugs of branded version is expected to restrain the growth of the market
  • Inadequate knowledge about dyspepsia in some developing countries can also hamper the market growth
  • Expensive screening test or treatment for dyspepsia can also restrict the growth of this market

Grab Your Report at an Impressive 30% Discount! Please click Here @

Segmentation: Global Dyspepsia Drug Market

By Classification

  • Organic Dyspepsia
  • Non-Ulcer Dyspepsia
  • Drug Induced Dyspepsia
  • Others

By Treatment Type

  • Medication
  • Surgery

By Drugs


o   Calcium Carbonate

o   Sodium Bicarbonate


o   Amoxicillin

o   Clarithromycin

o   Tetracycline

o   Tinidazole

H2 blockers

o   Cimetidine

o   Famotidine

o   Nizatidine

o   Ranitidine

Proton pump inhibitors (PPIs)

o   Esomeprazole

o   Lansoprazole

o   Omeprazole

o   Pantoprazole

o   Rabeprazole

Gastric Prokinetics Agents

o   Bethanechol

o   Metoclopramide

o   Mosapride

o   Domperidone


By Route of Administration

  • Oral
  • Injectable

By Distribution Channel

  • Online Pharmacy
  • Direct Tenders
  • Retailers
  • Others

By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Buy This Exclusive report At Special Discount @

Key Developments in the Market:

In March 2018, Eisai Co., Ltd has launched Cidine (cinitapride hydrogen tartrate), a gastrointestinal prokinetic agent in China for the treatment of mild-to-moderate functional dyspepsia (indigestion). The launch of Cidine in the China is set to change the treatment landscape for patients suffering from dyspepsia throughout China

In August 2016, LUPIN received approval from the Central Drugs Standard Control Organisation (CDSCO) for Acotiamide 100 mg tablets for the treatment of dyspepsia or indigestion. The approval of acotiamide represents a first-in-class novel disease specific treatment option for patients suffering from dyspepsia

Table of Contents:

1 Introduction

2 Research Methodologies

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Trends

7 Compliance in Dyspepsia Drug Market

8 Dyspepsia Drug Market, By Service

9 Dyspepsia Drug Market, By Deployment Type

10 Dyspepsia Drug Market, By Organization Size

11 Dyspepsia Drug Market Analyses, By Vertical

12 Geographic Analyses

North America



South America

Middle East & Africa

13 Competitive Landscapes

14 Detailed Company Profiles

15 Related Reports

Request for Detailed TOC:

Key Reasons To Purchase Dyspepsia Drug Report:

To gain insightful analyses of the market and have comprehensive understanding of the Global Dyspepsia Drug and its commercial landscape.

Assess the Dyspepsia Drug production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the Dyspepsia Drug and its impact in the Global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for Global Dyspepsia Drug.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.


Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475





Editor Details

  • Company:
    • CDN Newswire
Last Updated: 22-Feb-2021